Insider Transactions
| Date | Name | Title | Type | Filing | Shares Traded | Price Range | Total Held |
|---|---|---|---|---|---|---|---|
| Mar 06, 2008 | Ten Percent Owner | Open market or private purchase of non-derivative or derivative security | Form 4 | 2,100 | $9.98 | 902,996 | |
| Mar 06, 2008 | Director, Ten Percent Owner | Open market or private purchase of non-derivative or derivative security | Form 4 | 2,100 | $9.98 | 902,996 | |
| Oct 31, 2008 | Senior VP, Drug Development | Open market or private sale of non-derivative or derivative security | Form 4 | 2,200 | $10.00 | 49,116 | |
| Feb 07, 2008 | Ten Percent Owner | Open market or private purchase of non-derivative or derivative security | Form 4 | 2,200 | $10.08 | 558,582 | |
| Feb 07, 2008 | Director, Ten Percent Owner | Open market or private purchase of non-derivative or derivative security | Form 4 | 2,200 | $10.08 | 558,582 | |
| Feb 04, 2008 | Ten Percent Owner | Open market or private purchase of non-derivative or derivative security | Form 4 | 2,200 | $10.04 | 373,515 | |
| Feb 04, 2008 | Director, Ten Percent Owner | Open market or private purchase of non-derivative or derivative security | Form 4 | 2,200 | $10.04 | 373,515 | |
| Feb 01, 2008 | Ten Percent Owner | Open market or private purchase of non-derivative or derivative security | Form 4 | 2,200 | $9.35 | 323,315 | |
| Feb 01, 2008 | Ten Percent Owner | Open market or private purchase of non-derivative or derivative security | Form 4 | 2,200 | $9.54 | 340,450 | |
| Feb 01, 2008 | Director, Ten Percent Owner | Open market or private purchase of non-derivative or derivative security | Form 4 | 2,200 | $9.54 | 340,450 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.